Tag: anacor pharmaceuticals

Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing small-molecule therapeutics derived from its boron chemistry platform. The company’s lead product programs include AN2690, a topical antifungal product candidate in Phase 3 clinical development for the treatment of onychomycosis; AN2728, a topical anti-inflammatory PDE-4 inhibitor in Phase 2b clinical trial for the…